Finding a Cure for Fragile X
FRAXA Biotech Games™ are a “friendly” competition between greater Boston area biotech companies, their vendors and partners in a series of back yard lawn games including Cornhole, KanJam, Bucketball and Horseshoes. Who will earn bragging rights as the top company? Proceeds of the event support FRAXA Research Foundation, which funds Fragile X research in Boston, including Harvard, MIT, Tufts, MGH, and Boston Children’s Hospital.
Read moreFRAXA Biotech Games™ is a gathering of Boston area biotech companies to compete in backyard lawn games while raising money for a great cause! Proceeds benefit Fragile X research at Boston institutions such as MIT, Harvard, MGH and Boston Children’s Hospital.
Read more
FRAXA Biotech Games™, a gathering of Boston area biotech companies to network in a friendly setting, and form new relationships and potential collaborations while raising money for Fragile X research, is adapting its 2020 event to maintain its commitment to Fragile X and autism research while prioritizing the health and safety of its contestants and volunteers. The organization’s traditional annual event will be transformed into an online interactive experience September 9-11, 2020.
Read more
Read more
On September 20, 2018, FRAXA Research Foundation held the First Annual FRAXA Biotech Games™. The event was a “friendly” competition between greater Boston biotech companies and affiliated industry partners and vendors in a series of fun backyard lawn games. 42 teams of 4 players each played cornhole, KanJam, ladder golf and bucketball. Our goal was to establish an annual event in Cambridge, MA, that would unite the biotech community for an afternoon of fun competition, and raise money for biomedical research. We look forward to the upcoming Biotech Games!
Read more
The FRAXA Biotech Games exploded onto Cambridge Crossing with a capacity crowd. What was immediately obvious was the genuine camaraderie and mutual support of the biotech community and its many vendors to help raise awareness of and funds for research on Fragile X, the most common inherited cause of autism and intellectual disabilities.
Read more
Recently Laurie Bowler and her 19-year-old son Casey, who has Fragile X syndrome, visited FRAXA research grant recipient Dr. Tue Banke at his University of Washington laboratory. We hope you enjoy Laurie’s wonderful description of their adventure! FRAXA awarded $90,000 to Dr. Banke to study the Developmental Profile of Glutamatergic Synapses in Fragile X.
Read more
Many drugs for fragile X syndrome have failed in large clinical trials, but candidates that target new aspects of the condition may fare better.
Read more